Patents by Inventor Stefania CAPONE

Stefania CAPONE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPSTEIN-BARR VIRUS ANTIGEN CONSTRUCTS
    Publication number: 20240076318
    Abstract: The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
    Type: Application
    Filed: July 25, 2023
    Publication date: March 7, 2024
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Stefania CAPONE, Antonella FOLGORI, Armin LAHM, Benjamin WIZEL
  • Adenovirus polynucleotides and polypeptides
    Patent number: 11795478
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: October 24, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Virginia Ammendola, Stefania Capone, Stefano Colloca, Antonella Folgori, Rossella Merone
  • Epstein-barr virus antigen constructs
    Patent number: 11773139
    Abstract: The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: October 3, 2023
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Stefania Capone, Antonella Folgori, Armin Lahm, Benjamin Wizel
  • Simian adenovirus vectors comprising the ChAd-157 fiber protein
    Patent number: 11702674
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: July 18, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Virginia Ammendola, Stefania Capone, Stefano Colloca, Antonella Folgori, Rossella Merone
  • ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
    Publication number: 20220275397
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Application
    Filed: May 11, 2022
    Publication date: September 1, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Virginia AMMENDOLA, Stefania CAPONE, Stefano COLLOCA, Antonella FOLGORI, Rossella MERONE
  • Adenovirus polynucleotides and polypeptides
    Patent number: 11414679
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: August 16, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Virginia Ammendola, Stefania Capone, Stefano Colloca, Antonella Folgori, Rossella Merone
  • HETEROLOGOUS PRIME BOOST VACCINE COMPOSITIONS AND METHODS
    Publication number: 20220062409
    Abstract: Simian adenoviral vectors and RNA molecules, each encoding an immunogen of interest, can be sequentially administered to provide potent and long-lasting immunity.
    Type: Application
    Filed: December 13, 2019
    Publication date: March 3, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Stefania CAPONE, Nicolas Frederic DELAHAYE, Giulietta MARUGGI, Haifeng SONG
  • ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
    Publication number: 20210246468
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Application
    Filed: June 11, 2019
    Publication date: August 12, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Virginia AMMENDOLA, Stefania CAPONE, Stefano COLLOCA, Antonella FOLGORI, Rosella MERONE
  • EPSTEIN-BARR VIRUS ANTIGEN CONSTRUCTS
    Publication number: 20210198321
    Abstract: The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
    Type: Application
    Filed: December 14, 2018
    Publication date: July 1, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Stefania CAPONE, Antonella FOLGORI, Armin LAHM, Benjamin WIZEL
  • ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
    Publication number: 20190300905
    Abstract: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
    Type: Application
    Filed: December 7, 2017
    Publication date: October 3, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Virginia AMMENDOLA, Stefania CAPONE, Stefano COLLOCA, Antonella FOLGORI, Rosella MERONE